health promotion perspectives

[1] Do drug package inserts meet the rules and regulations of Iran's Food and Drug Administration in terms of informing patients?

[2] A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design

[3] Points to consider when establishing drug product specifications for parenteral microspheres.

[4] Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets.

[5] Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.

[6] Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot example

[7] in vitro release of diclofenac diethylamine from gels: evaluation of generic semisolid drug products in brazil

[8] development and validation of stability-indicating rp-hplc method for determination of olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of olmesartan medoxomile drug substance as well as drug product

[9] General Guidelines for the Clinical Evaluation of Anti-Infective Drug Products